These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2975806)

  • 1. Antidepressant-induced weight gain: a comparison study of four medications.
    Fernstrom MH; Kupfer DJ
    Psychiatry Res; 1988 Dec; 26(3):265-71. PubMed ID: 2975806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E; Salminen J; Lehtinen V
    J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zimelidine and amitriptyline in the treatment of depressive illness in general practice.
    Loudon JB; Tiplady B; Ashcroft GW; Waddell JL
    Acta Psychiatr Scand Suppl; 1981; 290():454-63. PubMed ID: 6452805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
    Montgomery SA; McAuley R; Rani SJ; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():314-27. PubMed ID: 6452798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D
    Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942
    [No Abstract]   [Full Text] [Related]  

  • 6. Double blind study comparing the efficacy of zimelidine and amitriptyline in endogenous depression.
    O'Connor M; Grigor J
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):127-32. PubMed ID: 6233635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder.
    Claghorn J; Gershon S; Goldstein BJ; Behrnetz S; Bush DF; Huitfeldt B
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):367-82. PubMed ID: 6225150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An electronic health records study of long-term weight gain following antidepressant use.
    Blumenthal SR; Castro VM; Clements CC; Rosenfield HR; Murphy SN; Fava M; Weilburg JB; Erb JL; Churchill SE; Kohane IS; Smoller JW; Perlis RH
    JAMA Psychiatry; 2014 Aug; 71(8):889-96. PubMed ID: 24898363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in body weight during pharmacological treatment of depression.
    Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Keers R; Gray JM; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Szczepankiewicz A; Kalember P; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
    Int J Neuropsychopharmacol; 2011 Apr; 14(3):367-75. PubMed ID: 20716398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Weight gain during antidepressant therapy].
    Sep-Kowalikowa B; Prokopowicz A; Pankiewicz P
    Psychiatr Pol; 1992; 26(1-2):37-43. PubMed ID: 1298003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between zimelidine and desipramine in endogenous depression. A cross-over study.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Aug; 66(2):129-38. PubMed ID: 6215831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion and amitriptyline in the treatment of depressed patients.
    Chouinard G
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):121-9. PubMed ID: 6406440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression.
    Amsterdam JD; Case WG; Csanalosi E; Singer M; Rickels K
    Pharmacopsychiatry; 1986 May; 19(3):115-9. PubMed ID: 2941771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricyclic-induced electroencephalogram abnormalities and plasma drug concentrations.
    Preskorn SH; Othmer SC; Lai CW; Othmer E
    J Clin Psychopharmacol; 1984 Oct; 4(5):262-4. PubMed ID: 6436340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight gain. A side-effect of tricyclic antidepressants.
    Berken GH; Weinstein DO; Stern WC
    J Affect Disord; 1984 Oct; 7(2):133-8. PubMed ID: 6238068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCA-induced mania: differences between switchers and nonswitchers.
    Nasrallah HA; Lyskowksi J; Schroeder D
    Biol Psychiatry; 1982 Feb; 17(2):271-4. PubMed ID: 7074184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.